Professor Paul G Overton

BA, PhD

School of Psychology

Professor of Neuroscience

Photo of Paul Overton
Profile picture of Photo of Paul Overton
P.G.Overton@sheffield.ac.uk
+44 114 222 6624
+44 114 276 6515 (fax)
Cathedral Court

Full contact details

Professor Paul G Overton
School of Psychology
Cathedral Court
1 Vicar Lane
Sheffield
S1 2LT
Qualifications

BA, PhD (Sheffield)

Research interests

My research interests largely revolve around the Basal Ganglia (and related structures), a group of nuclei implicated in a wide range of normal brain processes and neurological/ psychiatric disorders. At present, there are three main strands to my work:

1. Attention Deficit Hyperactivity Disorder

2. Non-motor deficits in Parkinson’s disease

3. Emotion processing

Publications

Show: Featured publications All publications

Journal articles

  • Vautrelle N, Coizet V, Leriche-Vazquez M, Dahan L, Schultz J, Zhang Y-F, Zeghbib A, Overton P, Bracci E, Redgrave P & Reynolds J (2023) . Current Neuropharmacology, 22(9), 1513-1527.
  • Favila N, Gurney K & Overton PG (2023) . Journal of Psychopharmacology, 37(6), 610-626.
  • Overton P, Dommett E, Dinu L, Singh S, Baker N, Georgescu A & Singer B (2023) . Behavioral Sciences, 13(2).
  • Al Tannir R, Pautrat A, Baufreton J, Overton P & Coizet V (2023) . Current Neuropharmacology, 21(1), 22-30.
  • Vivas AB, Hussain-Showaiter SM & Overton PG (2021) . Applied Neuropsychology, 30(4), 447-457.
  • Riley T & Overton P (2019) . Medical Hypotheses, 133.
  • Tsatali M, Overton P & Vivas A (2019) . PLoS ONE, 14(10).
  • Panagiotidi M, Overton PG & Stafford T (2019) . Journal of Attention Disorders, 23(12), 1407-1415.
  • Pautrat A, Rolland M, Barthelemy M, Baunez C, Sinniger V, Piallat B, Savaster M, Overton PG, David O & Coizet V (2018) . eLife, 7.
  • Turner A, Kraev I, Stewart M, Stramek A, Overton PG & Dommett E (2018) . Neuropharmacology, 138, 118-129.
  • Turner A, Stramek A, Kraev I, Stewarts M, Overton PG & Dommett E (2018) . Journal of Psychopharmacology, 32(8), 949-954.
  • Panagiotidi M, Overton PG & Stafford T (2017) . Acta Psychologica, 181, 10-17.
  • Veltri T, Taroyan N & Overton PG (2017) . Journal of Psychopharmacology, 31(7), 861-872.
  • Garlovsky JK, Simpson J, Grunewald RA & Overton PG (2016) . Psychology & Health, 31(12), 1391-1414.
  • Brace LR, Kraev I, Rostron CL, Stewart MG, Overton PG & Dommett EJ (2015) . Neuroscience, 303, 364-377.
  • Powell PA, Simpson J & Overton PG (2015) . Body Image, 12, 98-107.
  • Overton PG, Vautrelle N & Redgrave P (2014) . Neuroscience, 282, 1-12.
  • Clements KM, Devonshire IM, Reynolds JNJ & Overton PG (2014) . Neuroscience, 274, 289-298.
  • Bertram C, Dahan L, Boorman LW, Harris S, Vautrelle N, Leriche M, Redgrave P & Overton PG (2014) . J Neurophysiol, 111(4), 755-767.
  • Rolland M, Carcenac C, Overton PG, Savasta M & Coizet V (2013) . NEUROSCIENCE, 252, 277-288.
  • Harris S, Bruyns-Haylett M, Kennerley A, Boorman L, Overton PG, Ma H, Zhao M, Schwartz TH & Berwick J (2013) . J Cereb Blood Flow Metab, 33(10), 1595-1604.
  • Powell PA, Simpson J & Overton PG (2013) . Cogn Emot, 27(5), 900-913.
  • Clements KM, Smith LM, Reynolds JNJ, Overton PG, Thomas JD & Napper RM (2012) . Neurophysiology, 1-11.
  • Delaney M, Leroi I, Simpson J & Overton PG (2012) Impulse Control Disorders in Parkinson's Disease: A Psychosocial Perspective. Journal of Clinical Psychology in Medical Settings, 1-9.
  • Comoli E, Das Neves Favaro P, Vautrelle N, Leriche M, Overton PG & Redgrave P (2012) . Front Neuroanat, 6, 9.
  • Devonshire IM, Papadakis NG, Port M, Berwick J, Kennerley AJ, Mayhew JEW & Overton PG (2012) . Neuroimage, 59(3), 1997-2006.
  • Lepora NF, Overton PG & Gurney K (2012) . J Comput Neurosci, 32(1), 1-24.
  • Lepora NF, Blomeley CP, Hoyland D, Bracci E, Overton PG & Gurney K (2011) . Eur J Neurosci, 34(9), 1390-1405.
  • Coizet V, Dommett EJ, Klop EM, Redgrave P & Overton PG (2010) . Neuroscience, 168(1), 263-272.
  • Dommett EJ, Overton PG & Greenfield SA (2009) . NEUROSCIENCE, 164(3), 1369-1376.
  • Coizet V, Graham JH, Moss J, Bolam JP, Savasta M, McHaffie JG, Redgrave P & Overton PG (2009) . J Neurosci, 29(17), 5701-5709.
  • Gowan JD, Coizet V, Devonshire IM & Overton PG (2008) . J Neural Transm (Vienna), 115(3), 377-387.
  • Overton PG, Markland FE, Taggart HS, Bagshaw GL & Simpson J (2008) . Emotion, 8(3), 379-385.
  • Devonshire IM, Mayhew JEW & Overton PG (2007) . Neuroscience, 146(2), 841-851.
  • Aked J, Coizet V, Clark D & Overton PG (2005) . Neuroscience, 134(2), 361-367.
  • Dommett E, Coizet V, Blaha CD, Martindale J, Lefebvre V, Walton N, Mayhew JEW, Overton PG & Redgrave P (2005) . Science, 307(5714), 1476-1479.
  • Devonshire IM, Berwick J, Jones M, Martindale J, Johnston D, Overton PG & Mayhew JEW (2004) . Neuroimage, 22(4), 1744-1753.
  • Comoli E, Coizet V, Boyes J, Bolam JP, Canteras NS, Quirk RH, Overton PG & Redgrave P (2003) . Nat Neurosci, 6(9), 974-980.
  • Lokwan SJ, Overton PG, Berry MS & Clark D (2000) . Neuroscience, 95(3), 647-656.

All publications

Edited books

  • Powell PA, Overton PG & Simpson J (Eds.) (2014) The Revolting Self: Perspectives on the Psychological, Social, and Clinical Implications of Self-Directed Disgust. Karnac Books.

Journal articles

  • Varbanov V, Overton PG & Stafford T (2025) . Frontiers in Psychology, 16.
  • Jackson EF, Riley TB & Overton PG (2025) . Journal of Neurodevelopmental Disorders, 17(20).
  • Al Tannir R, Pautrat A, Soutrenon R, Overton PG & Coizet V (2025) . European Journal of Neuroscience, 61(7).
  • Robson A, Ypsilanti A, Lazuras L, Powell PA, Overton PG & Reidy J (2025) . Journal of Affective Disorders, 369, 1256-1266.
  • Azlan HA-N, Overton PG & Dommett EJ (2025) . Advances in Neurodevelopmental Disorders, 9(1), 157-167.
  • Overton P, Dommett E, Dinu L, Singer B, Byrom N, Georgescu A-L & Singh S (2024) . Behavioural Brain Research, 461.
  • Coizet V, Al Tannir R, Pautrat A & Overton PG (2024) . Current Neuropharmacology, 22(9), 1473-1490.
  • Favila N, Gurney K & Overton P (2024) . Reviews in the Neurosciences, 35(1), 35-55.
  • Albesisi S & Overton PG (2023) . Advances in Neurodevelopmental Disorders, 8(4), 627-637.
  • Dinu LM, Singh SN, Baker NS, Georgescu AL, Overton PG & Dommett EJ (2023) . PLOS ONE, 18(11).
  • Aristotelidou V, Overton PG & Vivas AB (2023) . PLoS ONE, 18(8).
  • Vautrelle N, Coizet V, Leriche-Vazquez M, Dahan L, Schultz J, Zhang Y-F, Zeghbib A, Overton P, Bracci E, Redgrave P & Reynolds J (2023) . Current Neuropharmacology, 22(9), 1513-1527.
  • Pautrat A, Al Tannir R, Pernet-Gallay K, Soutrenon R, Vendramini E, Sinniger V, Overton P, David O & Coizet V (2023) . npj Parkinson's Disease, 9.
  • Adkins K, Overton PG, Moses J & Thompson AR (2023) . JMIR Dermatology, 6.
  • Favila N, Gurney K & Overton PG (2023) . Journal of Psychopharmacology, 37(6), 610-626.
  • Overton P, Dommett E, Dinu L, Singh S, Baker N, Georgescu A & Singer B (2023) . Behavioral Sciences, 13(2).
  • Varbanov V, Overton PG & Stafford T (2023) . Current Psychology, 42(36), 32355-32367.
  • Al Tannir R, Pautrat A, Baufreton J, Overton P & Coizet V (2023) . Current Neuropharmacology, 21(1), 22-30.
  • Rusakov DA, Giese KP, Sandi C, Dommett E & Overton PG (2022) . Neuropharmacology, 207, 108962-108962.
  • Vivas AB, Stournaras S, Paraskevopoulos A & Overton PG (2022) . Journal of Gambling Studies, 38(2), 635-652.
  • Panagiotidi M & Overton P (2022) . Current Psychology, 41(5), 2765-2771.
  • Aristotleidou V, Tsatali M, Overton P & Vivas A (2021) . PLoS ONE, 16(9).
  • Vivas AB, Hussain-Showaiter SM & Overton PG (2021) . Applied Neuropsychology, 30(4), 447-457.
  • Favila N, Gurney K & Overton P (2021) . Neuropharmacology, 196.
  • Panagiotidi M & Overton P (2021) . Journal of Psychopathology and Behavioral Assessment, 43(3), 559-564.
  • Overton PG & Coizet V (2020) . Medical Hypotheses, 144.
  • Panagiotidi M, Overton P & Stafford T (2020) . Psychiatry Research, 293.
  • Ypsilanti A, Gettings R, Lazuras L, Robson A, Powell P & Overton P (2020) . Frontiers in Psychology, 11.
  • Azlan H, Overton P, Simpson J & Powell P (2020) . Journal of Behavioral Medicine, 43(3), 377-390.
  • Janmohammadi S, Haghgoo HA, Farahbod M, Overton P & Pishyareh E (2020) . Journal of Eye Movement Research, 12(8).
  • Ypsilanti A, Robson A, Lazuras L, Powell P & Overton P (2020) . Journal of Affective Disorders, 266, 646-654.
  • Taroyan N, Butnicu B, Ypsilanti A & Overton P (2020) . Frontiers in Behavioral Neuroscience, 14.
  • Riley T & Overton P (2019) . Medical Hypotheses, 133.
  • Tsatali M, Overton P & Vivas A (2019) . PLoS ONE, 14(10).
  • Stafford T, Overton PG & Hampsey E (2019) . Journal of Eye Movement Research, 12(6).
  • Lazuras L, Ypsilianti A, Powell P & Overton PG (2019) . Motivation and Emotion, 43(1), 145-158.
  • Ypsilanti A, Lazuras L, Powell P & Overton PG (2019) . Journal of Affective Disorders, 243, 108-115.
  • Panagiotidi M, Overton PG & Stafford T (2019) . Journal of Attention Disorders, 23(12), 1407-1415.
  • Burden N, Simpson J, Murray C, Overton PG & Powell P (2018) . Body Image, 27, 109-117.
  • Panagiotidi M & Overton PG (2018) . Comprehensive Psychiatry, 87, 7-11.
  • Pautrat A, Rolland M, Barthelemy M, Baunez C, Sinniger V, Piallat B, Savaster M, Overton PG, David O & Coizet V (2018) . eLife, 7.
  • Turner A, Kraev I, Stewart M, Stramek A, Overton PG & Dommett E (2018) . Neuropharmacology, 138, 118-129.
  • Turner A, Stramek A, Kraev I, Stewarts M, Overton PG & Dommett E (2018) . Journal of Psychopharmacology, 32(8), 949-954.
  • Turner A, Stramek A, Kraev I, Stewart M, Overton PG & Dommett E (2018) . Behavioural Brain Research, 343.
  • Panagiotidi M, Overton PG & Stafford T (2018) . Comprehensive Psychiatry, 80, 179-185.
  • Azlan HA, Overton PG, Simpson J & Powell PA (2017) . Journal of Clinical Psychology in Medical Settings, 24(3-4), 355-364.
  • Panagiotidi M, Overton PG & Stafford T (2017) . Acta Psychologica, 181, 10-17.
  • Hetherington L, Dommett E, Turner A, Riley T, Haensel J & Overton PG (2017) . Journal of Psychopharmacology, 31(10), 1347-1361.
  • Buxton D, Bracci E, Overton PG & Gurney K (2017) . Frontiers in Computational Neuroscience, 11.
  • Veltri T, Taroyan N & Overton PG (2017) . Journal of Psychopharmacology, 31(7), 861-872.
  • Panagiotidi M, Overton P & Stafford T (2017) . Journal of Eye Movement Research, 10(1).
  • Panagiotidi M, Overton PG & Stafford T (2017) . Perception, 46(6), 665-678.
  • Azlan HA, Overton PG, Simpson J & Powell PA (2017) . Psychology and Health, 32(1), 19-37.
  • Garlovsky JK, Overton PG & Simpson J (2016) . Journal of Clinical Psychology, 72(10), 979-998.
  • Garlovsky JK, Simpson J, Grunewald RA & Overton PG (2016) . Psychology & Health, 31(12), 1391-1414.
  • Powell PA, Azlan HA, Simpson J & Overton PG (2016) . Journal of Behavioral Medicine, 39(4), 560-573.
  • Brace LR, Kraev I, Rostron CL, Stewart MG, Overton PG & Dommett EJ (2015) . Brain Research, 1629, 10-25.
  • Brace LR, Kraev I, Rostron CL, Stewart MG, Overton PG & Dommett EJ (2015) . Neuroscience, 303, 364-377.
  • Powell PA, Simpson J & Overton PG (2015) . Body Image, 12, 98-107.
  • Overton PG, Vautrelle N & Redgrave P (2014) . Neuroscience, 282, 1-12.
  • Harris S, Boorman L, Bruyns-Haylett M, Kennerley A, Ma H, Zhao M, Overton PG, Schwartz TH & Berwick J (2014) . Epilepsia, 55(9), 1423-1430.
  • Harris S, Ma H, Zhao M, Boorman L, Zheng Y, Kennerley A, Bruyns-Haylett M, Overton PG, Berwick J & Schwartz TH (2014) . Neuroimage, 97, 62-70.
  • Clements KM, Devonshire IM, Reynolds JNJ & Overton PG (2014) . Neuroscience, 274, 289-298.
  • Bertram C, Dahan L, Boorman LW, Harris S, Vautrelle N, Leriche M, Redgrave P & Overton PG (2014) . J Neurophysiol, 111(4), 755-767.
  • Powell PA, Overton PG & Simpson J (2013) . Journal of Clinical Psychology.
  • Rolland M, Carcenac C, Overton PG, Savasta M & Coizet V (2013) . NEUROSCIENCE, 252, 277-288.
  • Harris S, Bruyns-Haylett M, Kennerley A, Boorman L, Overton PG, Ma H, Zhao M, Schwartz TH & Berwick J (2013) . J Cereb Blood Flow Metab, 33(10), 1595-1604.
  • Powell PA, Simpson J & Overton PG (2013) . Cogn Emot, 27(5), 900-913.
  • Clements KM, Smith LM, Reynolds JNJ, Overton PG, Thomas JD & Napper RM (2012) . Neurophysiology, 1-11.
  • Delaney M, Leroi I, Simpson J & Overton PG (2012) Impulse Control Disorders in Parkinson's Disease: A Psychosocial Perspective. Journal of Clinical Psychology in Medical Settings, 1-9.
  • Comoli E, Das Neves Favaro P, Vautrelle N, Leriche M, Overton PG & Redgrave P (2012) . Front Neuroanat, 6, 9.
  • Devonshire IM, Papadakis NG, Port M, Berwick J, Kennerley AJ, Mayhew JEW & Overton PG (2012) . Neuroimage, 59(3), 1997-2006.
  • Lepora NF, Overton PG & Gurney K (2012) . J Comput Neurosci, 32(1), 1-24.
  • Siegal M, Fadda R & Overton PG (2011) . Philos Trans R Soc Lond B Biol Sci, 366(1583), 3427-3432.
  • Lepora NF, Blomeley CP, Hoyland D, Bracci E, Overton PG & Gurney K (2011) . Eur J Neurosci, 34(9), 1390-1405.
  • Simpson J, Hillman R, Crawford T & Overton PG (2010) . MOTIV EMOTION, 34(4), 399-406.
  • Coizet V, Dommett EJ, Klop EM, Redgrave P & Overton PG (2010) . Neuroscience, 168(1), 263-272.
  • Simpson J, Hillman R, Crawford T & Overton PG (2010) Self-esteem and self-disgust both mediate the relationship between dysfunctional cognitions and depressive symptoms. Motivation and Emotion, 1-8.
  • Redgrave P, Coizet V, Comoli E, McHaffie JG, Leriche M, Vautrelle N, Hayes LM & Overton P (2010) . Front Neuroanat, 4.
  • Dommett EJ, Overton PG & Greenfield SA (2009) . NEUROSCIENCE, 164(3), 1369-1376.
  • Coizet V, Graham JH, Moss J, Bolam JP, Savasta M, McHaffie JG, Redgrave P & Overton PG (2009) . J Neurosci, 29(17), 5701-5709.
  • Overton PG & Devonshire IM (2008) . Bioscience Hypotheses, 1(2), 70-77.
  • Gowan JD, Coizet V, Devonshire IM & Overton PG (2008) . J Neural Transm (Vienna), 115(3), 377-387.
  • Overton PG (2008) . Med Hypotheses, 70(6), 1121-1127.
  • Overton PG, Markland FE, Taggart HS, Bagshaw GL & Simpson J (2008) . Emotion, 8(3), 379-385.
  • Devonshire IM, Mayhew JEW & Overton PG (2007) . Neuroscience, 146(2), 841-851.
  • Simpson J, Anthony SH, Schmeer S & Overton PG (2007) . FOOD QUAL PREFER, 18(2), 183-189.
  • Coizet V, Overton PG & Redgrave P (2007) . J Comp Neurol, 500(6), 1034-1049.
  • Dommett EJ, Simpson J, Clark D & Overton PG (2007) . J Neural Transm (Vienna), 114(2), 161-172.
  • Simpson J, Carter S, Anthony SH & Overton PG (2006) . MOTIV EMOTION, 30(1), 31-41.
  • Coizet V, Dommett EJ, Redgrave P & Overton PG (2006) . Neuroscience, 139(4), 1479-1493.
  • McHaffie JG, Jiang H, May PJ, Coizet V, Overton PG, Stein BE & Redgrave P (2006) . Neuroscience, 138(1), 221-234.
  • Aked J, Coizet V, Clark D & Overton PG (2005) . Neuroscience, 134(2), 361-367.
  • Dommett E, Coizet V, Blaha CD, Martindale J, Lefebvre V, Walton N, Mayhew JEW, Overton PG & Redgrave P (2005) . Science, 307(5714), 1476-1479.
  • Berwick J, Devonshire IM, Martindale AJ, Johnston D, Zheng Y, Kennerley AJ, Overton PG & Mayhew JEW (2005) . Neuroscience, 132(2), 361-374.
  • Devonshire IM, Berwick J, Jones M, Martindale J, Johnston D, Overton PG & Mayhew JEW (2004) . Neuroimage, 22(4), 1744-1753.
  • Gurney KN & Overton PG (2004) . NEUROCOMPUTING, 58-60, 555-562.
  • Comoli E, Coizet V, Boyes J, Bolam JP, Canteras NS, Quirk RH, Overton PG & Redgrave P (2003) . Nat Neurosci, 6(9), 974-980.
  • Overton PG, Marrow LP, Brain PF & Clark D (2000) . Addict Biol, 5(3), 283-288.
  • Overton PG, Lokwan SJ, Berry MS & Clark D (2000) . J Neural Transm (Vienna), 107(12), 1381-1391.
  • Lokwan SJ, Overton PG, Berry MS & Clark D (2000) . Neuroscience, 95(3), 647-656.
  • Marrow L, Statham A, Overton PG, Brain PF & Clark D (1999) . Addict Biol, 4(1), 89-92.
  • Marrow LP, Overton PG, Brain PF & Clark D (1999) . Addict Biol, 4(4), 437-441.
  • Lokwan SJ, Overton PG, Berry MS & Clark D (1999) . Neuroscience, 92(1), 245-254.
  • Overton PG, Richards CD, Berry MS & Clark D (1999) . Neuroreport, 10(2), 221-226.
  • Marrow LP, Overton PG & Brain PF (1999) . Journal of Psychopharmacology, 13, 115-121.
  • Clark D & Overton PG (1998) Alterations in excitatory amino acid-mediated regulation of midbrain dopaminergic neurones induced by chronic psychostimulant administration and stress: relevance to behavioural sensitization and drug addiction. ADDICT BIOL, 3(2), 109-135.
  • Tong ZY, Overton PG, Martinez-Cué C & Clark D (1998) . Exp Brain Res, 118(4), 466-476.
  • Overton PG & Clark D (1997) . Brain Res Brain Res Rev, 25(3), 312-334.
  • Tong ZY, Overton PG & Clark D (1996) Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events.. Synapse, 22(3), 195-208.
  • Tong ZY, Overton PG & Clark D (1996) . J Neural Transm (Vienna), 103(8-9), 889-904.
  • Overton PG, Tong ZY & Clark D (1996) . J Neural Transm (Vienna), 103(5), 523-540.
  • Overton PG, Tong ZY, Brain PF & Clark D (1996) . Brain Res, 737(1-2), 146-154.
  • Overton PG, O'Callaghan JF & Greenfield SA (1995) . Exp Brain Res, 107(2), 151-165.
  • Tong ZY, Overton PG & Clark D (1995) . Brain Res, 674(1), 63-74.
  • Overton PG & Greenfield SA (1995) . Journal of Neural Transmission, 10, 41-54.
  • Marrow L, Overton P & Clark D (1993) Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat.. Behav Pharmacol, 4(1), 15-28.
  • Overton P & Clark D (1992) . Synapse, 10(2), 131-140.
  • Overton P, Elliott PJ, Hagan RM & Clark D (1992) . Eur J Pharmacol, 213(1), 165-166.
  • Overton P & Clark D (1992) . J Neural Transm Park Dis Dement Sect, 4(1), 1-14.
  • MARROW L, OVERTON P & CLARK D (1992) AMELIORATION OF SOME NEUROLEPTIC-INDUCED DEFICITS BY THE NMDA ANTAGONIST MK-801 IN A CONDITIONED REACTION-TIME-TASK. BEHAV PHARMACOL, 3(1), 57-64.
  • Redgrave P, Simkins M, overton P & Dean P (1992) . Neuroscience, 46(2), 379-390.
  • Overton P & Clark D (1991) . Eur J Pharmacol, 201(1), 117-120.
  • Overton P & Dean P (1988) . Behav Brain Res, 31(1), 1-15.
  • Overton P, Dean P & Redgrave P (1985) . Exp Brain Res, 59(3), 559-569.
  • Overton P, Luo J, Wen S, Wu Y, Huang H, Gaoyang X, Yanjie Q, Yi Z & Fan H () A Network Analysis of ADHD and ASD Symptoms in Chinese Children: Insights on Age and Gender Differences. International Journal of Methods in Psychiatric Research.
  • Overton P, Adkin K, Thompson A & Moses J () Unhelpful social media use? Investigating the role of upwards comparisons and self-compassion on stigma in people with acne. Frontiers in Medicine.
  • Gibson F, Overton P, Smulders T, Schultz S, Eglen S, Ingram C, Panzeri S, Bream P, Whittington M, Sernagor E , Cunningham M et al () . Nature Precedings.

Book chapters

  • Favila N & Overton PG (2025) , Substance P (pp. 159-178). Elsevier

Datasets

  • Overton P (2021) Autonomic factors do not underlie elevated self-disgust levels in Parkinson's disease.
  • Overton P, Vivas A & Tsatali M .

Preprints

  • VARBANOV V, Overton P & Stafford T (2024) , Center for Open Science.
  • VARBANOV V, Overton P & Stafford T (2022) , Center for Open Science.
Research group

Grants

Current grants:

  • Title: Can a dysfunction of the basal ganglia and related low level nociceptive network underlie some central neuropathic pain symptoms in Parkinson’s disease? Coizet, V [PI], Baunez, C., Bandmann, O, Overton, P.G.Total funding (£): 573,868 Funding body: CoEN (MRC)

Past grants:

  • Overton, P.G. [PI], Gluing behaviours together - 'chunking' in the normal brain and its disruption in Parkinson's disease. Rosetrees Trust (£5450; 2018-2019)
  • Overton, P.G., Billington, T. [PI] Attention and behaviour: Transforming achievement and social inclusion following primary-secondary school transition. ESRC Collaborative studentship (£65.983; 2016-2020).
  • Overton, P.G,., Dommett, E.J. [PI], Singer, B., Byrom, N. Investigating the effects of cardio and non-cardio exercise on adults with Attention Deficit Hyperactivity Disorder. Rosetrees Trust (£59,282; 2019-2020).
Teaching activities

I am module organiser for PSY6306 (Fundamentals of Neuroscience).

PhD Opportunities

I am happy to receive applications for ¾Ã²Ý¸£Àû in my area of research.

We advertise PhD opportunities (Funded or Self-Funded) on 

For further information, please see the department PhD Opportunities page.

Links